Industry News
Using sugar to detect malignant tumours
2/22/2016
Ordinary sugar could become a contrast agent of the future for use in magnetic resonance tomography examinations of tumours. Malignant tumours show higher sugar consumption than surrounding tissue.
Consensus on genomic classification of bladder cancer makes progress
2/22/2016
A meeting to agree a genomic classification for bladder cancer reaches consensus on BASQ: a group of basal-squamous-like tumors based on the genes KRT5/6, KRT14, FOXA1 and GATA3.
Shape-shifting engineered nanoparticles for delivering cancer drugs to tumors
2/22/2016
Professor Warren Chan designs modular nanoparticles attached to strands of DNA that can change shape to gain access to diseased tissue, like a key fitting into a lock.
Scientists discover secret to promising new cancer drug
2/22/2016
Researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment.
Biochemical alteration responsible for brain tumor resistance identified
2/22/2016
Glioblastoma is the most aggressive manifestation of brain tumours. Due to its high invasive capacity and uncontrolled, infiltrating growth, it is particularly difficult to manage.
Patients with no schooling benefit least from blood thinning medications
2/22/2016
Atrial fibrillation patients with low education miss treatment targets more often.
Is height, weight linked to rise in non-Hodgkin's lymphoma?
2/22/2016
Non-Hodgkin's lymphoma has been on the rise for the last 30 years. The reasons for this are unclear, but investigations into height and weight are yielding fresh clues.
Scientists discover secret to promising new cancer drug
2/22/2016
Researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment.
Is height, weight linked to rise in non-Hodgkin's lymphoma?
2/22/2016
Non-Hodgkin's lymphoma has been on the rise for the last 30 years. The reasons for this are unclear, but investigations into height and weight are yielding fresh clues.
Patients with no schooling benefit least from blood thinning medications
2/22/2016
Atrial fibrillation patients with low education miss treatment targets more often.
